Brand Transition

OzeScribe is iMedX in Australia

Our website and emails are changing, but our people, service, and quality are not!

In 2019 iMedX will be completing the final phase of the OzeScribe acquisition in Australia by phasing out the OzeScribe brand. This is to better align the branding across multiple Clinical Information solutions which we offer in Australia, New Zealand and the United States – not just transcription!

Frequently Asked Questions

What is changing?

Our website address and email addresses will both be changing to reflect the iMedX brand. Our new website will be accessible at Our emails will change to

What will happen if send an email to an address?

Your emails will still be answered as all contact points will have your messages automatically forwarded to their respective address. You will receive a response from an address.

What will happen if I visit an web page?

You will automatically be sent to the new page on that matches what you were looking for on the old website. To avoid a slight delay which occurs from forwarding we recommend you update any bookmarks to the new webpage. However, that is not required.

What else is changing?

Nothing! The locally managed Australian operations team based in Melbourne will remain unchanged and continue to manage your service across all sales, account management, invoicing and support roles! Similarly, our phone and fax numbers will remain unchanged.